Joel Slade

Title: The Innovations of Joel Slade

Introduction

Joel Slade is an accomplished inventor based in Carmel, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as angiotensin-converting enzyme inhibitors and antihypertensive agents. His work has the potential to impact the treatment of hypertension and related conditions.

Latest Patents

Joel Slade holds a patent for "Hetero-benzazepine derivatives and their pharmaceutical use." This patent discloses variously substituted 3-(carboxymethylamino)-(1,5-benzothiazepin-4-one, 1,5-benzoxazepin-4-one, and 1,5-benzodiazepin-4-one)-5-alkanoic acids and derivatives. These compounds are designed to function as angiotensin-converting enzyme inhibitors and antihypertensive agents. The patent also includes details on their synthesis, pharmaceutical compositions, and methods of treatment utilizing such compounds.

Career Highlights

Joel Slade is associated with Ciba-Geigy Corporation, where he has been able to apply his innovative ideas in a corporate setting. His work at the company has allowed him to collaborate with other talented professionals in the field.

Collaborations

One of his notable coworkers is James L. Stanton. Their collaboration has likely contributed to the advancement of their projects and the successful development of new pharmaceutical solutions.

Conclusion

Joel Slade's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare. His work continues to pave the way for advancements in the treatment of hypertension and related conditions.